SCHEMBL19009701

SCHEMBL19009701

c1ccc(-c2nc3c4ccccc4c4ccccc4c3c3ccc(-c4c5ccccc5c(-c5cccnc5)c5ccccc45)cc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.43
CYP19A1 P11511 3/20 0.38
CYP11B2 P19099 2/20 0.38
CYP17A1 P05093 1/20 0.38
CHEK1 O14757 1/20 0.38
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 2/20 0.38
HSD17B1 P14061 1/20 0.38
CYP2B6 P20813 1/20 0.38
HSD17B2 P37059 1/20 0.38
PIM1 P11309 1/20 0.37
PIM3 Q86V86 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
DHODH Q02127 1/20 0.37
GPR84 Q9NQS5 1/20 0.37
KDM4E B2RXH2 4/20 0.36
IDO1 P14902 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19009724 0.84 CYP11B1 (0.45) CYP11B1CYP19A1CYP11B2CYP17A1CYP1A2
SCHEMBL19009699 0.83 CYP11B1 (0.46) CYP11B1CYP19A1CYP11B2CYP17A1CYP1A2
SCHEMBL19009710 0.82 ADORA2A (0.43) CYP1A2CYP3A4CYP2C19KDM4EHPGD
SCHEMBL19009692 0.82 CYP11B1 (0.47) CYP11B1CYP19A1CYP11B2CYP17A1CYP1A2
SCHEMBL19009762 0.80 MKNK1 (0.36) CHEK1HSD17B1HSD17B2DHODHKDM4E
SCHEMBL19009694 0.80 ALDH1A1 (0.35) CYP3A4CYP2C9DHODHKDM4EHPGD
SCHEMBL19009738 0.79 CYP11B1 (0.43) CYP11B1CYP19A1CYP11B2CYP17A1CYP1A2
SCHEMBL19020493 0.79 ADORA2A (0.38) KDM4EADORA2AADORA1ALDH1A1SMN1; SMN2
SCHEMBL19009746 0.79 CYP11B1 (0.43) CYP11B1CYP19A1CYP11B2CYP17A1CYP1A2
SCHEMBL19009717 0.78 CSNK2A2 (0.44) CYP11B1CYP19A1CYP11B2CYP17A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP11B1 341/4885CYP19A1 65/4885CYP11B2 467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.